Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids.

[1]  T. Falcone,et al.  Alternatives to hysterectomy: The burden of fibroids and the quality of life. , 2018, Best practice & research. Clinical obstetrics & gynaecology.

[2]  N. Aaronson,et al.  Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study. , 2017, European journal of cancer.

[3]  S. Vitale,et al.  Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease , 2017, Archives of Gynecology and Obstetrics.

[4]  M. Martinho,et al.  Update on medical treatment of uterine fibroids. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[5]  K. Wernecke,et al.  Fears and Concerns of Patients with Uterine Fibroids – a Survey of 807 Women Ängste und Befürchtungen von Myompatientinnen – Ergebnisse einer Befragung von 807 Patientinnen , 2017, Geburtshilfe und Frauenheilkunde.

[6]  S. Wagenpfeil,et al.  Postoperative Quality of Life and Sexual Function in Premenopausal Women Undergoing Laparoscopic Myomectomy for Symptomatic Fibroids: A Prospective Observational Cohort Study , 2016, PloS one.

[7]  J. Donnez,et al.  Uterine fibroid management: from the present to the future , 2016, Human reproduction update.

[8]  D. Barlow,et al.  Long-term medical management of uterine fibroids with ulipristal acetate. , 2016, Fertility and sterility.

[9]  B. Borah,et al.  Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: a cohort study. , 2015, Fertility and sterility.

[10]  K. Cameron,et al.  Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health. , 2015, Journal of psychosomatic research.

[11]  I. Osterloh,et al.  Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. , 2015, Fertility and sterility.

[12]  I. Osterloh,et al.  Long-term treatment of uterine fibroids with ulipristal acetate ☆. , 2014, Fertility and sterility.

[13]  Wen-zhi Chen,et al.  Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy , 2013, Archives of Gynecology and Obstetrics.

[14]  I. Osterloh,et al.  Ulipristal acetate versus placebo for fibroid treatment before surgery. , 2012, The New England journal of medicine.

[15]  I. Osterloh,et al.  Ulipristal acetate versus leuprolide acetate for uterine fibroids. , 2012, The New England journal of medicine.

[16]  S. Bolge,et al.  The burden of uterine fibroids in five European countries. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[17]  E. Tok,et al.  The effect of myomectomy on health‐related quality of life of women with myoma uteri , 2010, The journal of obstetrics and gynaecology research.

[18]  J. de Vries,et al.  Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. , 2009, Fertility and sterility.

[19]  E. Tok,et al.  The effect of myoma uteri and myomectomy on sexual function. , 2009, The journal of sexual medicine.

[20]  E. Arleo,et al.  Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter? , 2007, International journal of fertility and women's medicine.

[21]  J. Cuzick,et al.  The Sexual Activity Questionnaire: A measure of women's sexual functioning , 1996, Quality of Life Research.

[22]  R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston,.  The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function , 2000 .